STOCK TITAN
  1. Home
  2. Sec-filings
  3. QURE
  4. [Form 4] uniQure N.V. Insider Trading Activity

uniQure (QURE) director sells 6,390 shares in Rule 10b5-1 plan trade

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

uniQure N.V. director Jack Kaye reported exercising stock options and selling shares of the company on January 9, 2026. He exercised a stock option to buy 6,390 Ordinary Shares at an exercise price of $19.39 per share, then sold the same 6,390 Ordinary Shares at a weighted average price of $27.28 per share under transaction code "S".

These trades were carried out under a pre-arranged Rule 10b5-1 sales plan adopted on June 16, 2025, as described in the footnotes. After the reported transactions, Kaye directly owned 20,439 Ordinary Shares of uniQure N.V.

Positive

  • None.

Negative

  • None.
Insider Kaye Jack
Role Director
Sold 6,390 shs ($174K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 6,390 $0.00 --
Exercise Ordinary Shares 6,390 $19.39 $124K
Sale Ordinary Shares 6,390 $27.28 $174K
Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Ordinary Shares — 26,829 shares (Direct)
Footnotes (1)
  1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Stock Option vested in full on January 26, 2019.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kaye Jack
(Last) (First) (Middle)
C/O UNIQURE N.V.
PAASHEUVELWEG 25A
(Street)
AMSTERDAM P7 11058BP
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 01/09/2026 M(1) 6,390 A $19.39 26,829 D
Ordinary Shares 01/09/2026 S(1) 6,390 D $27.28(2) 20,439 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $19.39 01/09/2026 M(1) 6,390 (3) 01/26/2028 Ordinary Shares 6,390 $0 0 D
Explanation of Responses:
1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The Stock Option vested in full on January 26, 2019.
/s/ Christian Klemt, Attorney-in-Fact 01/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did uniQure (QURE) director Jack Kaye report?

Jack Kaye reported exercising a stock option for 6,390 Ordinary Shares at $19.39 per share and selling 6,390 Ordinary Shares at a weighted average price of $27.28 on January 9, 2026.

How many uniQure (QURE) shares does Jack Kaye own after this Form 4?

Following the reported transactions, Jack Kaye directly owned 20,439 Ordinary Shares of uniQure N.V..

Was the uniQure (QURE) insider sale made under a Rule 10b5-1 plan?

Yes. The footnotes state the transactions were effected under a sales plan adopted on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

What type of derivative security did Jack Kaye exercise at uniQure (QURE)?

He exercised a Stock Option (Right to Buy) covering 6,390 Ordinary Shares at an exercise price of $19.39 per share. The option had vested in full on January 26, 2019.

What price range were the uniQure (QURE) shares sold for in this Form 4?

The sale price reported is a weighted average of $27.28 per share. The footnotes state the shares were sold in multiple transactions at prices ranging from $27.19 to $27.39.

Is Jack Kaye a major shareholder of uniQure (QURE)?

In this filing, Jack Kaye is identified as a Director of uniQure N.V. and is not marked as a 10% owner.